Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
45.53 USD | +0.04% |
|
+1.29% | -15.04% |
07/05 | DA Davidson Adjusts Price Target on USANA Health Sciences to $46 From $48, Maintains Neutral Rating | MT |
01/05 | Transcript : USANA Health Sciences, Inc., Q1 2024 Earnings Call, May 01, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.04% | 867M | |
+13.80% | 8.09B | |
+0.47% | 7.39B | |
-8.08% | 5.37B | |
-6.84% | 3.63B | |
-19.73% | 3.27B | |
-12.00% | 1.19B | |
-26.87% | 1.13B | |
+0.89% | 879M | |
-12.86% | 846M |
- Stock Market
- Equities
- USNA Stock
- News USANA Health Sciences, Inc.
- Earnings Flash (USNA) USANA HEALTH SCIENCES Posts Q1 Revenue $227.8M, vs. Street Est of $226.8M